Personalization Of Vasopressor Therapy In The Treatment Of Vasodilatory Shock
b'In this episode of Critical Matters, listen to the recording of Sound Critical Care\\u2019s webinar, Personalized Selection of Vasopressors in the Treatment of Shock. Our guest for this episode is Dr. Lakhmir Chawla, Chief Medical Officer of La Jolla Pharmaceutical in San Diego, California.\\n\\nDuring this webinar, we discuss lessons learned from the clinical use of the new vasopressor Angiotensin II, as well as personalization of vasopressor therapy in the treatment of vasodilatory shock.\\n\\nWatch the video recording: https://bit.ly/2jZ1z5h'